Stéphane H. Bogen
Affiliations: | 1997-1998 | Indiana University, Bloomington, Bloomington, IN, United States |
Google:
"Stéphane Bogen"Mean distance: 7.74 | S | N | B | C | P |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Bogen S, Gulea M, Fensterbank L, et al. (2019) 5-Endo-Trig Radical Cyclizations of Bromomethyldimethylsilyl Diisopropylpropargylic Ethers. A Highly Diastereoselective Access to Functionalized Cyclopentanes. The Journal of Organic Chemistry. 64: 4920-4925 |
Bogen S, Fensterbank L, Malacria M. (2019) Study of a Radical Cyclizations Cascade Leading to Bicyclo[3.1.1]heptanes. The Journal of Organic Chemistry. 64: 819-825 |
Girijavallabhan V, Arasappan A, Bennett F, et al. (2016) 2'-Modified Guanosine Analogs for the Treatment of HCV. Nucleosides, Nucleotides & Nucleic Acids. 1-18 |
Dang Q, Zhang Z, Bai Y, et al. (2014) Syntheses of nucleosides with a 1′,2′-β-lactam moiety as potential inhibitors of hepatitis C virus NS5B polymerase Tetrahedron Letters. 55: 5576-5579 |
Dang Q, Zhang Z, Chen T, et al. (2014) Syntheses of 1′,2′-cyclopentyl nucleosides as potential antiviral agents Tetrahedron Letters. 55: 5092-5095 |
Dang Q, Zhang Z, He S, et al. (2014) Syntheses of 4′-spirocyclic phosphono-nucleosides as potential inhibitors of hepatitis C virus NS5B polymerase Tetrahedron Letters. 55: 4407-4409 |
Dang Q, Zhang Z, Tang B, et al. (2014) Syntheses of nucleosides with 2′-spirolactam and 2′- spiropyrrolidine moieties as potential inhibitors of hepatitis C virus NS5B polymerase Tetrahedron Letters. 55: 3813-3816 |
Wang Y, Lipari P, Mirza A, et al. (2012) Abstract 2785: Discovery of a novel HDM2 inhibitor with potent in vivo anti-tumor activity Cancer Research. 72: 2785-2785 |
Velázquez F, Sannigrahi M, Bennett F, et al. (2010) Cyclic sulfones as novel P3-caps for hepatitis C virus NS3/4A (HCV NS3/4A) protease inhibitors: synthesis and evaluation of inhibitors with improved potency and pharmacokinetic profiles. Journal of Medicinal Chemistry. 53: 3075-85 |
Nair LG, Bogen S, Ruan S, et al. (2010) Towards the second generation of Boceprevir: Dithianes as an alternative P2 substituent for 2,2-dimethyl cycloproyl proline in HCV NS3 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 20: 1689-92 |